India sends USD 2 million in medical aid to Nepal under Neighbourhood First Policy
New Delhi [India], April 25 (ANI): India on Friday reaffirmed its commitment to the Neighbourhood First Policy by sending USD 2 million worth of medical aid to Nepal.
The assistance includes medicines and vaccines for patients with Thalassemia and Sickle Cell Disease. The first tranche of this aid consists of 17,030 vials of vaccines for the immunisation of Thalassemia patients.
Sharing a post on X, Ministry of External Affairs spokesperson Randhir Jaiswal wrote, 'Reaffirming India's commitment to Neighbourhood First Policy. India sends assistance consisting of medicines and vaccines for patients with Thalassemia and Sickle Cell Disease worth $2 million, responding to a request from Nepal.'
The post added, 'The 1st tranche of 17,030 vials of Vaccines for Immunisation of patients with Thalassemia was handed over to Nepal.'
https://x.com/MEAIndia/status/1915649226077282349
The Neighbourhood First policy guides the management of India's relations with countries in its immediate neighbourhood, focuses on creating mutually beneficial, people-oriented, regional frameworks for stability and prosperity, including through the building of physical, digital and people-to-people connectivity.
India engages with these countries on a consultative, non-reciprocal and outcome-oriented basis, driven by the principles of Samman (respect), Samvad (dialogue), Shanti (peace), and Samriddhi (prosperity).
As part of India's Neighbourhood First policy, the Government has been extending necessary developmental assistance and capacity-building initiatives, as per the needs and aspirations of the neighbouring countries, thereby contributing towards the holistic economic development of their countries. Under this approach, India has been assisting neighbouring countries in the development of infrastructure projects ranging from large-scale infrastructure to community-related provisioning of assets and platforms, augmentation of capabilities and extending financial, budgetary and humanitarian assistance.
India's assistance under its Neighbourhood First policy is regarded as valuable by diverse sections of public opinion among our neighbours, ensuring a sustainable basis for these assistance programs to continue despite changes in administration in these countries. Government keeps a vigilant watch on all developments which have a bearing on India's national security and takes all necessary measures to safeguard it. (ANI)
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Standard
an hour ago
- Business Standard
Zydus Lifesciences receives USFDA tentative approval for Rifaximin Tablets
Zydus Lifesciences has received tentative approval from the United States Food and Drug Administration (USFDA) for Rifaximin Tablets, 550 mg (USRLD: Xifaxan Tablets, 550 mg). Rifaximin tablets are indicated for the treatment of irritable bowel syndrome with diarrhoea (IBS-D) in adults. Rifaximin tablets will be produced at the Group's manufacturing site at SEZ II, Ahmedabad. Rifaximin tablets had annual sales of USD $2672.9 mn in the United States (IQVIA MAT March 2025).
India Gazette
3 hours ago
- India Gazette
India's health insurance sector faces growth and profitability challenges: Report
New Delhi [India], June 2 (ANI): India's health insurance industry, which was earlier considered a strong and steady growth story, is now facing serious structural challenges. A recent report by Elara Capital has highlighted that both growth and profitability in the sector are being affected, which may redefine the long-term potential of health insurers in the country. It said, 'India's health insurance industry, long seen as a secular growth story, is facing structural constraints in terms of growth as well as profitability'. According to the report, one of the key reasons behind this slowdown is the overestimation of the total addressable market (TAM) for private insurers. Many experts had earlier projected a large market for private health insurance. However, with the expansion of government-sponsored health schemes that offer widespread coverage, the actual market available for private players has reduced. This has made it more difficult for private insurers to grow at the pace previously expected. At the same time, increasing competition in the sector is adding more pressure. The report noted that factors such as a shift in policy mix toward older or vintage policies and the growing bargaining power of hospitals and insurance distributors are affecting the profitability of health insurance companies. These trends are putting a cap on the margins of insurance manufacturers. The report also pointed to the entry of LIC into the health insurance segment, along with other life insurance companies that are expected to enter through composite licenses. This will further intensify competition and could limit growth opportunities for traditional standalone health insurers (SAHI). Due to these challenges, the report advised investors to lower their long-term expectations for broad-based growth in the health insurance sector. Instead, they should focus on more resilient areas such as third-party administrators (TPAs) and diversified multi-line private general insurers, which tend to have stronger business models and better profitability. Another concern is the rising cost of claims. The report explained that after COVID-19, there has been a shift in focus toward critical illnesses like cancer and heart conditions. This has led to higher claim frequency and severity, putting additional pressure on insurers. Loss ratios remain high, and the situation is worsened by increasing hospital occupancy, which has gone up from 52 per cent in FY21 to 64 per cent in FY25. Along with this, the average revenue per occupied bed (ARPOB) has grown at a compound annual growth rate (CAGR) of around 10 per cent, further driving up the cost of claims. In summary, the report highlighted that India's health insurance sector is going through a structural change. While traditional players may face limited growth, new opportunities exist in niche segments with better economics. (ANI)
India Gazette
11 hours ago
- India Gazette
Odisha reports 12 COVID-19 cases with mild symptoms; officials urge calm as Omicron variants detected
Bhubaneswar (Odisha) [India], June 1 (ANI): The Director of Public Health, Government of Odisha, Dr. Nilakantha Mishra, on Sunday said that the number of active COVID-19 cases in the state has risen to 12, further adding that the patients had mild symptoms and were being treated in isolation. 'The number was 9 yesterday, and three more cases were detected today, bringing the total to 12. The number of cases is very low, and almost all patients diagnosed with COVID have mild symptoms. They are being treated in isolation in their own homes,' Dr Mishra told ANI. He further reassured the public, stating that the variants detected in the state are sub-lineages of Omicron, and there is no cause for concern at this point.'There is nothing to worry about in Odisha. The variants that have been detected are also Omicron variants,' he added. On May 31, Odisha Health Secretary had said that authorities were closely monitoring the situation and holding regular review meetings, as the total number of COVID-19 cases across India rose to 2,710, with Kerala reporting the highest number of active cases. On the current COVID-19 situation in Odisha, Commissioner-cum-Secretary of the Health and Family Welfare Department of the state, Aswathy S, told ANI, 'It is well within control. We have only seven identified positive cases. The first one has already recovered. There is no threat to the public at the moment. We are monitoring the situation. We are assessing the preparedness. We are conducting regular meetings.' According to the Union Health Ministry, India's COVID-19 tally has reached 2,710 active cases, with 1,170 patients discharged. The country reported seven deaths across multiple states, with comorbidities playing a significant role in most cases, according to state-wise data. According to the Health Ministry, in Delhi, one death was reported--a 60-year-old female with acute intestinal obstruction post-laparotomy, where Covid-19 was an incidental finding. Gujarat recorded one death, with details still awaited. Karnataka reported one fatality--a 70-year-old male who succumbed to acute cardiorespiratory arrest, acute encephalopathy with late-onset focal seizure, severe anaemia, thrombocytopenia, and comorbidities including diabetes mellitus (DM), hypertension (HTN), and ischemic heart disease (IHD). His COVID-19 status awaits RT-PCR confirmation, as per the statement. (ANI)
